Topical 0.5% Ivermectin Cream for Treatment of Demodicidosis
Status:
Unknown status
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether 0.5% ivermectin cream is effective in the
treatment of demodicidosis (including papulopustular rosacea)